Longen Zhou

854 total citations
18 papers, 688 citations indexed

About

Longen Zhou is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Longen Zhou has authored 18 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Longen Zhou's work include Microtubule and mitosis dynamics (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Longen Zhou is often cited by papers focused on Microtubule and mitosis dynamics (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Longen Zhou collaborates with scholars based in United States, Singapore and China. Longen Zhou's co-authors include David D. Roberts, Phang‐Lang Chen, Guikai Wu, Henry C. Krutzsch, Wen‐Hwa Lee, Xiaolong Qiu, Jiewen Zhu, Nancy Smyth Templeton, Saori Furuta and Irene Kuhn and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Longen Zhou

18 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longen Zhou United States 12 436 215 158 151 95 18 688
Christoph Roesli Switzerland 17 481 1.1× 242 1.1× 121 0.8× 142 0.9× 114 1.2× 28 918
Gina L. Razidlo United States 15 512 1.2× 204 0.9× 187 1.2× 88 0.6× 114 1.2× 23 789
Iwao Ohizumi Japan 13 392 0.9× 154 0.7× 115 0.7× 126 0.8× 100 1.1× 23 729
Tatsiana Kosciuk United States 10 317 0.7× 216 1.0× 153 1.0× 119 0.8× 110 1.2× 10 677
Cédric Leroy France 13 524 1.2× 255 1.2× 91 0.6× 107 0.7× 75 0.8× 20 871
Soula Ganiatsas United States 9 614 1.4× 248 1.2× 122 0.8× 156 1.0× 79 0.8× 10 829
Yuanyan Wei China 20 657 1.5× 373 1.7× 115 0.7× 200 1.3× 204 2.1× 35 949
Stephen I. Rudnick United States 9 391 0.9× 270 1.3× 89 0.6× 165 1.1× 52 0.5× 11 798
Yulong Liang China 20 890 2.0× 280 1.3× 185 1.2× 125 0.8× 212 2.2× 48 1.1k
Nicole St‐Denis Canada 11 713 1.6× 166 0.8× 191 1.2× 79 0.5× 57 0.6× 11 901

Countries citing papers authored by Longen Zhou

Since Specialization
Citations

This map shows the geographic impact of Longen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longen Zhou more than expected).

Fields of papers citing papers by Longen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longen Zhou. The network helps show where Longen Zhou may publish in the future.

Co-authorship network of co-authors of Longen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Longen Zhou. A scholar is included among the top collaborators of Longen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longen Zhou. Longen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Leung, Elaine Lai‐Han, Runze Li, Xing‐Xing Fan, et al.. (2023). Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy. Nature Communications. 14(1). 5115–5115. 14 indexed citations
3.
Mustafa, Nurulhuda, Jing Yuan Chooi, Tae‐Hoon Chung, et al.. (2021). Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma. Journal for ImmunoTherapy of Cancer. 9(7). e002123–e002123. 9 indexed citations
4.
Mustafa, Nurulhuda, Jing Yuan Chooi, Viknesvaran Selvarajan, et al.. (2018). CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma. Blood. 132(Supplement 1). 1663–1663. 4 indexed citations
5.
Pink, Desmond, Keith A. Luhrs, Longen Zhou, et al.. (2015). High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model. Scientific Reports. 5(1). 15756–15756. 7 indexed citations
6.
Tiron, Crina, Gro Gausdal, Tone Sandal, et al.. (2014). Abstract 1747: BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies. Cancer Research. 74(19_Supplement). 1747–1747. 12 indexed citations
7.
Gausdal, Gro, Tone Sandal, Stefan Hinz, et al.. (2014). Abstract B30: Selective small molecule AXL inhibitor BGB324 overcomes acquired drug resistance in non-small cell lung carcinoma models.. Clinical Cancer Research. 20(2_Supplement). B30–B30. 1 indexed citations
8.
Zhu, Jiewen, Longen Zhou, Guikai Wu, et al.. (2013). A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia. EMBO Molecular Medicine. 5(3). 353–365. 74 indexed citations
9.
Furuta, Saori, Yung‐Ming Jeng, Longen Zhou, et al.. (2011). Supplementary Materials for IL-25 Causes Apoptosis of IL-25R-Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells. 14 indexed citations
10.
Furuta, Saori, Yung‐Ming Jeng, Longen Zhou, et al.. (2011). IL-25 Causes Apoptosis of IL-25R–Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells. Science Translational Medicine. 3(78). 78ra31–78ra31. 95 indexed citations
11.
Qiu, Xiaolong, Guideng Li, Guikai Wu, et al.. (2009). Synthesis and Biological Evaluation of a Series of Novel Inhibitor of Nek2/Hec1 Analogues. Journal of Medicinal Chemistry. 52(6). 1757–1767. 53 indexed citations
12.
Wu, Guikai, Xiaolong Qiu, Longen Zhou, et al.. (2008). Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in Animal. Cancer Research. 68(20). 8393–8399. 92 indexed citations
13.
Wu, Guikai, Longen Zhou, Xuning Emily Guo, et al.. (2008). A novel role of the chromokinesin Kif4A in DNA damage response. Cell Cycle. 7(13). 2013–2020. 61 indexed citations
14.
Isenberg, Jeff S., Marı́a J. Calzada, Longen Zhou, et al.. (2005). Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor. Matrix Biology. 24(2). 110–123. 50 indexed citations
15.
Calzada, Marı́a J., Longen Zhou, John M. Sipes, et al.. (2003). α 4 β 1 Integrin Mediates Selective Endothelial Cell Responses to Thrombospondins 1 and 2 In Vitro and Modulates Angiogenesis In Vivo. Circulation Research. 94(4). 462–470. 83 indexed citations
16.
Wang, Wenjie, et al.. (2003). [Effects of musk glucoprotein on chemotaxis of polymorphonuclear leukocytes in vivo and in vitro].. PubMed. 28(1). 59–62. 5 indexed citations
17.
Zhou, Longen, et al.. (2002). Identification of heat shock protein 60 as a molecular mediator of alpha 3 beta 1 integrin activation.. PubMed. 62(5). 1541–8. 87 indexed citations
18.
Guo, Neng‐Hua, Longen Zhou, John M. Sipes, et al.. (2001). Conformational Regulation of the Fibronectin Binding and α3β1 Integrin-mediated Adhesive Activities of Thrombospondin-1. Journal of Biological Chemistry. 276(30). 27913–27922. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026